[HTML][HTML] Exploring novel therapeutic targets in the common pathogenic factors in migraine and neuropathic pain

J Tajti, D Szok, A Csáti, Á Szabó, M Tanaka… - International Journal of …, 2023 - mdpi.com
Migraine and neuropathic pain (NP) are both painful, disabling, chronic conditions which
exhibit some symptom similarities and are thus considered to share a common etiology. The …

[HTML][HTML] Biomarkers of migraine: an integrated evaluation of preclinical and clinical findings

C Demartini, M Francavilla, AM Zanaboni… - International journal of …, 2023 - mdpi.com
In recent years, numerous efforts have been made to identify reliable biomarkers useful in
migraine diagnosis and progression or associated with the response to a specific treatment …

Migraine, neurogenic inflammation, drug development-pharmacochemical aspects

M Lukacs, J Tajti, F Fulop, J Toldi… - Current medicinal …, 2017 - ingentaconnect.com
Background: Migraine is a primary headache disorder. Despite numerous studies conducted
with the aim to understand the pathophysiology of migraine, several aspects are still unclear …

[HTML][HTML] Are migraine with and without aura really different entities?

ZT Kincses, D Veréb, P Faragó, E Tóth, K Kocsis… - Frontiers in …, 2019 - frontiersin.org
Background: Migraine research is booming with the rapidly developing neuroimaging tools.
Structural and functional alterations of the migrainous brain were detected with MRI. The …

Major targets involved in clinical management of migraine

R Rushendran, V Chitra, K Ilango - Current Neurovascular …, 2023 - ingentaconnect.com
Background: There has been a protracted effort to identify reliable targets for migraine. It is
believed that each year, hundreds of millions of individuals worldwide suffer from migraines …

Treating status migrainosus in the emergency setting: what is the best strategy?

L Vécsei, D Szok, A Nyári, J Tajti - Expert Opinion on …, 2018 - Taylor & Francis
Introduction: Migraine is a disabling primary headache disorder with unknown exact
pathomechanism. Status migrainosus (SM) is a complication of migraine (with or without …

Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives

P Courault, G Demarquay, L Zimmer… - Fundamental & …, 2021 - Wiley Online Library
Cluster headache (CH) is the most common form of trigeminal autonomic cephalalgia.
Current treatments have several limitations, and new drugs are required. This article first …

The therapeutic impact of new migraine discoveries

L Vécsei, M Lukács, J Tajti, F Fülöp… - Current medicinal …, 2019 - ingentaconnect.com
Background: Migraine is one of the most disabling neurological conditions and associated
with high socio-economic costs. Though certain aspects of the pathomechanism of migraine …

[PDF][PDF] EREDETI KÖZLEMÉNY THE EFFECT OF PSYCHIATRIC COMORBIDITIES AND STRESS-COPING STRATEGIES ON PERCEIVED QUALITY OF LIFE IN …

A Petrovics-Balog, Z Majláth, M Lukács… - SZEMLE …, 2019 - academia.edu
Purpose–Migraine is one of the most disabling primary headache conditions. We aimed to
detect hidden symptoms of anxiety and depression and to survey stress-coping mechanisms …

Therapeutic strategies that act on the peripheral nervous system in primary headache disorders

J Tajti, D Szok, A Nyári, L Vécsei - Expert Review of …, 2019 - Taylor & Francis
Introduction: Acute and preventive treatment of primary headache disorders is not
completely resolved with regard to efficacy, safety, and tolerability. Hence, peripheral and …